Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson’s progression

A recent study in Nature Medicine evaluated the efficacy of prasinezumab, a monoclonal antibody, in slowing the progression of motor symptoms in Parkinson’s disease patients with rapidly progressing forms, using phase II clinical trial data.

CareCloud, Google Cloud Partner to Bring Generative AI to Ambulatory Practices

What You Should Know: – Google Cloud and CareCloud, today announced a strategic partnership that will bring the power of generative AI to small and

July 27, 2023

Bruker to acquire Nanostring for $393M

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Scientific instruments maker Bruker will

April 18, 2024

From data to action: Igniting the healthcare revolution – Pharmaceutical Technology

As healthcare demands continue to surge, innovation is an ever-pressing necessity. At the heart of this transformation lies a precious resource, capable of revolutionising care

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.